GRPR and brain cancer: Wang and colleagues developed the optical probe IRDye800–RM26 (9) targeting the gastrin-releasing peptide receptor (GRPR) for NIR-II fluorescence imaging and intraoperative guidance in malignant brain tumors (Figure 15a,b) [154].